News
In late March 2025, Donna Nguyen’s life changed when she heard one word. That word carries a deep and powerful stigma, but ...
AINU launches campaign in Chennai to raise awareness about prostate cancer, emphasizing early screening and robotic surgery ...
Doctors are warning of a looming treatment crisis with annual prostate cancer diagnoses projected to double to 8000 by 2045.
New Zealand’s healthcare system faces a mounting crisis as prostate cancer diagnoses are projected to double over the next 20 years, while the country continues to lag behind international best ...
A new study co-authored by Tracy Crane, Ph.D., RDN, co-leader of the Cancer Control Program at Sylvester Comprehensive Cancer ...
Doctors are warning of a looming treatment crisis with annual prostate cancer diagnoses projected to double to 8000 by 2045.
Anyone who’s heard the “C-word” and their name in the same sentence will confirm this: You go deaf. You hear the next few words, but you don’t hear them. Because cancer reverberates in your brain like ...
The Healthy @Reader's Digest on MSN
New Prostate Cancer Treatment Options You Should Know About, From a Urologic Surgeon
A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...
Regenerative medicine company Orthocell Limited (ASX:OCC, "Orthocell" or the "Company") is pleased to announce its flagship nerve repair device, Remplir, has been introduced to Urologists in Australia ...
Regenerative medicine company Orthocell (ASX: OCC) has introduced its flagship nerve repair device Remplir to Australian ...
TipRanks on MSN
Orthocell Expands Remplir’s Use in Prostate Cancer Surgeries
Orthocell Ltd ( ($AU:OCC) ) just unveiled an announcement. Orthocell Ltd has announced the use of its nerve repair device, Remplir, in ...
Globally Significant Opportunity Emerges as Remplir is used in Nerve-Sparing Prostate Cancer Surgery
Potential to reduce the risk of erectile dysfunction and urinary incontinence PERTH, Australia, Sept. 16, 2025 /PRNewswire/ --Regenerative medicine company Orthocell Limited (ASX:OCC, "Orthocell" or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results